» Articles » PMID: 28685276

Post-trimodality Expression Levels of Metadherin (MTDH) As a Prognostic Biomarker for Esophageal Adenocarcinoma Patients

Abstract

Resectable esophageal adenocarcinoma (EAC) patients often receive chemoradiation followed by surgery. However, most patients experience recurrences. Overexpression of MTDH, an oncoprotein with multiple functions, has been found to be associated with poor prognosis in breast cancer, glioblastoma, melanoma and various gastrointestinal malignancies, but not in EAC. We sought to establish its role in resistant EAC (post-treatment residual EAC). MTDH was assessed by immunohistochemistry in resected EAC, and results were correlated with clinical outcomes. MTDH expression was detectable in 72.5% (50/69) of patients, while expression levels were high (positive) in 50.7% (35/69). Of 69 patients analyzed, 25 had no relapse and 44 patients had a relapse (8 with local-regional and 36 with distant). The median follow-up duration was 3 years (0.4-11.6). The median overall survival was not associated with MTDH status (2.79 years for MTDH-negative and 3.60 years for MTDH-positive patients, p = 0.121). In addition, MTDH was not associated with either the type of relapse (local or distant), baseline clinical stage, tumor grade, presence of signet ring cells, surgical (yp) stage, percentage of residual EAC or presence of lymphovascular invasion. Our data reveal that MTDH is not a prognostic biomarker in resistant EAC after trimodality therapy.

Citing Articles

The Scope of Astrocyte Elevated Gene-1/Metadherin (AEG-1/MTDH) in Cancer Clinicopathology: A Review.

Khan M, Sarkar D Genes (Basel). 2021; 12(2).

PMID: 33671513 PMC: 7927008. DOI: 10.3390/genes12020308.


MicroRNA‑98/PTEN/AKT pathway inhibits cell proliferation and malignant progression of hypopharyngeal carcinoma by MTDH.

Wang Q, Tan L, Liu J, Zhao J, Zhou X, Yu T Oncol Rep. 2018; 41(2):863-874.

PMID: 30535507 PMC: 6313011. DOI: 10.3892/or.2018.6904.


MiR-30b-5p modulates glioma cell proliferation by direct targeting MTDH.

Zhang D, Liu Z, Zheng N, Wu H, Zhang Z, Xu J Saudi J Biol Sci. 2018; 25(5):947-952.

PMID: 30108445 PMC: 6087807. DOI: 10.1016/j.sjbs.2018.02.015.

References
1.
Li S, Guo X, Ma X, Tang C, Ke Z, Huang W . Expression of astrocyte elevated gene-1 closely correlates with the angiogenesis of gastric cancer. Oncol Lett. 2014; 7(5):1447-1454. PMC: 3997719. DOI: 10.3892/ol.2014.1950. View

2.
Yang C, Zheng S, Liu Q, Liu T, Lu M, Dai F . Metadherin is required for the proliferation, migration, and invasion of esophageal squamous cell carcinoma and its meta-analysis. Transl Res. 2015; 166(6):614-626.e2. DOI: 10.1016/j.trsl.2015.05.004. View

3.
Jian-Bo X, Hui W, Yu-Long H, Zhang Chang-hua , Long-juan Z, Shi-Rong C . Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer. Med Oncol. 2010; 28(2):455-62. DOI: 10.1007/s12032-010-9475-6. View

4.
Baygi M, Nikpour P . Deregulation of MTDH gene expression in gastric cancer. Asian Pac J Cancer Prev. 2012; 13(6):2833-6. DOI: 10.7314/apjcp.2012.13.6.2833. View

5.
Yu C, Chen K, Zheng H, Guo X, Jia W, Li M . Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis. 2009; 30(5):894-901. DOI: 10.1093/carcin/bgp064. View